AMN HEALTHCARE SERVICES INC (AMN) Fundamental Analysis & Valuation

NYSE:AMN • US0017441017

Current stock price

18.49 USD
+0.1 (+0.54%)
At close:
18.69 USD
+0.2 (+1.08%)
After Hours:

This AMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AMN Profitability Analysis

1.1 Basic Checks

  • AMN had positive earnings in the past year.
  • AMN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AMN reported negative net income in multiple years.
  • Each year in the past 5 years AMN had a positive operating cash flow.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.57%, AMN is doing worse than 66.00% of the companies in the same industry.
  • AMN has a worse Return On Equity (-14.90%) than 62.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.73%, AMN is doing worse than 60.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AMN is below the industry average of 8.86%.
  • The 3 year average ROIC (6.19%) for AMN is well above the current ROIC(1.73%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -4.57%
ROE -14.9%
ROIC 1.73%
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • AMN has a worse Operating Margin (1.21%) than 60.00% of its industry peers.
  • In the last couple of years the Operating Margin of AMN has declined.
  • The Gross Margin of AMN (28.35%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of AMN has declined.
Industry RankSector Rank
OM 1.21%
PM (TTM) N/A
GM 28.35%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AMN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMN is destroying value.
  • The number of shares outstanding for AMN has been increased compared to 1 year ago.
  • AMN has less shares outstanding than it did 5 years ago.
  • AMN has a better debt/assets ratio than last year.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.44 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.44, AMN is in line with its industry, outperforming 59.00% of the companies in the same industry.
  • AMN has a debt to FCF ratio of 3.28. This is a good value and a sign of high solvency as AMN would need 3.28 years to pay back of all of its debts.
  • AMN has a better Debt to FCF ratio (3.28) than 70.00% of its industry peers.
  • A Debt/Equity ratio of 1.19 is on the high side and indicates that AMN has dependencies on debt financing.
  • AMN has a Debt to Equity ratio of 1.19. This is in the lower half of the industry: AMN underperforms 63.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 3.28
Altman-Z 2.44
ROIC/WACC0.22
WACC7.79%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.94 indicates that AMN may have some problems paying its short term obligations.
  • With a Current ratio value of 0.94, AMN is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.94 indicates that AMN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.94, AMN is doing worse than 71.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AMN Growth Analysis

3.1 Past

  • The earnings per share for AMN have decreased strongly by -58.91% in the last year.
  • The earnings per share for AMN have been decreasing by -16.94% on average. This is quite bad
  • Looking at the last year, AMN shows a decrease in Revenue. The Revenue has decreased by -8.49% in the last year.
  • The Revenue has been growing slightly by 2.67% on average over the past years.
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%

3.2 Future

  • Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 52.37% on average per year.
  • AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.67% yearly.
EPS Next Y36.65%
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%
EPS Next 5Y52.37%
Revenue Next Year17.16%
Revenue Next 2Y-0.37%
Revenue Next 3Y1.06%
Revenue Next 5Y7.67%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. AMN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.60, which indicates a correct valuation of AMN.
  • AMN's Price/Earnings ratio is rather cheap when compared to the industry. AMN is cheaper than 84.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.54. AMN is valued slightly cheaper when compared to this.
  • AMN is valuated reasonably with a Price/Forward Earnings ratio of 9.95.
  • Based on the Price/Forward Earnings ratio, AMN is valued cheaper than 90.00% of the companies in the same industry.
  • AMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 13.6
Fwd PE 9.95
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 82.00% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
  • AMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMN is cheaper than 97.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.06
EV/EBITDA 7.61
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A cheap valuation may be justified as AMN's earnings are expected to decrease with -7.38% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMN Dividend Analysis

5.1 Amount

  • No dividends for AMN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMN Fundamentals: All Metrics, Ratios and Statistics

AMN HEALTHCARE SERVICES INC

NYSE:AMN (3/24/2026, 5:43:59 PM)

After market: 18.69 +0.2 (+1.08%)

18.49

+0.1 (+0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners103.39%
Inst Owner Change-1.08%
Ins Owners0.38%
Ins Owner Change8.99%
Market Cap714.45M
Revenue(TTM)2.73B
Net Income(TTM)-95.70M
Analysts69.23
Price Target22.66 (22.55%)
Short Float %5.68%
Short Ratio1.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.78%
Min EPS beat(2)-21.51%
Max EPS beat(2)93.07%
EPS beat(4)3
Avg EPS beat(4)60.31%
Min EPS beat(4)-21.51%
Max EPS beat(4)116.02%
EPS beat(8)7
Avg EPS beat(8)40.9%
EPS beat(12)11
Avg EPS beat(12)30.43%
EPS beat(16)15
Avg EPS beat(16)25.36%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.64%
Max Revenue beat(2)2.36%
Revenue beat(4)3
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)2.36%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)7
Avg Revenue beat(12)0.85%
Revenue beat(16)11
Avg Revenue beat(16)1.44%
PT rev (1m)6.51%
PT rev (3m)7.24%
EPS NQ rev (1m)1320.88%
EPS NQ rev (3m)1232.99%
EPS NY rev (1m)172.37%
EPS NY rev (3m)140.7%
Revenue NQ rev (1m)94.61%
Revenue NQ rev (3m)94.31%
Revenue NY rev (1m)24.16%
Revenue NY rev (3m)24.01%
Valuation
Industry RankSector Rank
PE 13.6
Fwd PE 9.95
P/S 0.26
P/FCF 3.06
P/OCF 2.65
P/B 1.11
P/tB N/A
EV/EBITDA 7.61
EPS(TTM)1.36
EY7.36%
EPS(NY)1.86
Fwd EY10.05%
FCF(TTM)6.05
FCFY32.73%
OCF(TTM)6.97
OCFY37.72%
SpS70.66
BVpS16.62
TBVpS-10.28
PEG (NY)0.37
PEG (5Y)N/A
Graham Number22.55
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -14.9%
ROCE 2.19%
ROIC 1.73%
ROICexc 1.77%
ROICexgc 5.91%
OM 1.21%
PM (TTM) N/A
GM 28.35%
FCFM 8.56%
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
ROICexc(3y)6.27%
ROICexc(5y)13.02%
ROICexgc(3y)21.12%
ROICexgc(5y)45.11%
ROCE(3y)7.84%
ROCE(5y)15.78%
ROICexgc growth 3Y-59.99%
ROICexgc growth 5Y-29.62%
ROICexc growth 3Y-59.19%
ROICexc growth 5Y-26.95%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
F-Score5
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 3.28
Debt/EBITDA 4.04
Cap/Depr 22.75%
Cap/Sales 1.3%
Interest Coverage 0.74
Cash Conversion 141.99%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 2.44
F-Score5
WACC7.79%
ROIC/WACC0.22
Cap/Depr(3y)44.93%
Cap/Depr(5y)49.12%
Cap/Sales(3y)2.27%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
EPS Next Y36.65%
EPS Next 2Y-8.75%
EPS Next 3Y-7.38%
EPS Next 5Y52.37%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
Revenue Next Year17.16%
Revenue Next 2Y-0.37%
Revenue Next 3Y1.06%
Revenue Next 5Y7.67%
EBIT growth 1Y-72.31%
EBIT growth 3Y-62.85%
EBIT growth 5Y-30.5%
EBIT Next Year231.17%
EBIT Next 3Y39.54%
EBIT Next 5YN/A
FCF growth 1Y-2.38%
FCF growth 3Y-25.82%
FCF growth 5Y1.44%
OCF growth 1Y-15.9%
OCF growth 3Y-25.58%
OCF growth 5Y0.97%

AMN HEALTHCARE SERVICES INC / AMN Fundamental Analysis FAQ

What is the fundamental rating for AMN stock?

ChartMill assigns a fundamental rating of 3 / 10 to AMN.


Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?

ChartMill assigns a valuation rating of 7 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Undervalued.


How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?

AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 2 / 10.


What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?

The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to grow by 36.65% in the next year.